A theme focused on expanding development collaborations with public research institutions and companies in Japan and overseas, and strengthening international information networks, in order to accelerate the introduction and practical application of clinical pipeline candidates. This includes expanding the disease areas covered by partnerships, such as joint research with Kyushu University on brain tumors using CAR-eNK cells.